In the latest Minimum Data Set (MDS), effective on Oct. 1, providers will need to pay close attention to definition changes, ...

Treatment for myelodysplastic syndromes has gradually advanced in anemia management and targeted therapies, according to Dr.

The MEDALIST trial was a phase 3 study with patients with ESA-refractory, low-risk MDS who require transfusions. In this ...

Research can be a valuable part of the premedical journey and a great addition to the medical school application, but many applicants worry they'll be asked about it in interviews and freeze.

Tamibarotene plus azacitidine for higher-risk myelodysplastic syndrome shows no added benefit in phase 3 trial.

Here is a rundown of the initial enrollment period timeline: ■ Enroll anytime three months before you turn 65, and your ...

The National Medical Commission (NMC) has issued new guidelines to all medical schools and institutes across the country for ...

The National Medical Commission (NMC) has directed all medical colleges to follow interim guidelines for MBBS admissions of ...

AD, the test measures epigenetic markers in mitochondrial DNA to assess the likelihood that a person with mild cognitive impairment will progress to dementia.